FR2356418A1 - Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acids - Google Patents
Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acidsInfo
- Publication number
- FR2356418A1 FR2356418A1 FR7620134A FR7620134A FR2356418A1 FR 2356418 A1 FR2356418 A1 FR 2356418A1 FR 7620134 A FR7620134 A FR 7620134A FR 7620134 A FR7620134 A FR 7620134A FR 2356418 A1 FR2356418 A1 FR 2356418A1
- Authority
- FR
- France
- Prior art keywords
- iii
- beta
- admin
- mucous membranes
- pantothenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Medicaments to regenerate the gastric mucous membranes contain pantothenic acid (I) together with desoxyribonucleic acid (II) and beta-glycyrrhetinic acid (III). The presence of (II) and (III) increases the known activity of (I). Typically compsns. contain 60 wt. % (I), 30 wt. % (II) and 10 wt.% (III) 200 mg. of the combination being given 3 times daily. The daily admin. to rats to 120mg. (I) 60mg. (II) and 20mg. (III) per kg. for 90 days was without toxic symptoms. The pref. wt. ratio of (Ied(II):(III) is 60:30:10. The daily dosage of such a combination is 3x200mg.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7620134A FR2356418A1 (en) | 1976-07-01 | 1976-07-01 | Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7620134A FR2356418A1 (en) | 1976-07-01 | 1976-07-01 | Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2356418A1 true FR2356418A1 (en) | 1978-01-27 |
FR2356418B1 FR2356418B1 (en) | 1978-12-15 |
Family
ID=9175120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7620134A Granted FR2356418A1 (en) | 1976-07-01 | 1976-07-01 | Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acids |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2356418A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668665A (en) * | 1982-10-27 | 1987-05-26 | Chugai Seiyaku Kabushiki Kaisha | Formulation of sucralfate |
-
1976
- 1976-07-01 FR FR7620134A patent/FR2356418A1/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668665A (en) * | 1982-10-27 | 1987-05-26 | Chugai Seiyaku Kabushiki Kaisha | Formulation of sucralfate |
Also Published As
Publication number | Publication date |
---|---|
FR2356418B1 (en) | 1978-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1458414A (en) | Composition and method of treatin ulcers | |
KR890003391A (en) | Calcium supplements | |
JPS5353636A (en) | Preparatin of highly pure aromatic dicarboxylic acid dichloride | |
FR2356418A1 (en) | Regeneration of gastric mucous membranes - by admin. of pantothenic, desoxy-ribonucleic, and beta-glycyrrhetinic acids | |
MY128187A (en) | Preparation for skin and mucous membrane | |
Tollström et al. | Effects of prostaglandins E 2 and 552-01552-01552-01on motility of small intestine in man | |
DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
JPS5225772A (en) | Preparation of molecular compound of allantoin and ornithine | |
IE42425L (en) | Aryloxy and arylthio-alkanoates having cholesterol-reducing¹properties. | |
IE55973B1 (en) | The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis | |
EP0317933A3 (en) | Treatment of fibromyalgia | |
JPS5665825A (en) | Remedy for peptic ulcer | |
JPS523047A (en) | Preparation of di-(t-alkyl) anthraquinones | |
JPS5610114A (en) | Novel analgesic and anti-inflammatory agent | |
FR2449446A1 (en) | Anti-obesity compsn. contg. tri: or tetra:iodo:thyro:acetic acid - with metformine or salt to enhance activity | |
JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
SU596595A1 (en) | Potassium cobalt-diaquo-bisdicyclo (2,2,1) hept-5-ene-2,3-endo-cisdihydroxamate as 0,0-dimethyl-0,2,2-dichlorvinylphosphate antidote | |
JPS539758A (en) | Preparation of santonin derivatives | |
JPS5225771A (en) | Preparation of molecular compound of allantoin and lysine | |
JPS5775922A (en) | Novel remedy for peptic ulcer | |
AU1237076A (en) | Preparation of 0-[2,6-dichloroanilino] phenyl-acetic acid [diclofenac] | |
JPS51131824A (en) | Process for preparation of diglycollic acid | |
JPS5473128A (en) | Blood lipid depressing agent | |
JPS5271410A (en) | Preparation of unaturated diesters | |
JPS5489037A (en) | Anti-ulcer agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |